Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Medical Alley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medical Alley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Future of TAVR with Wayne Paterson of Anteris Technologies

22:39
 
Share
 

Manage episode 465884542 series 2892873
Content provided by Medical Alley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medical Alley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

On this episode of The Medical Alley Podcast, we have a conversation with Wayne Paterson, CEO and Managing Director of Anteris Technologies.

In late December of 2024, Anteris Technologies launched an IPO to support the development of DurAVR, a Transcatheter Heart Valve (THV) designed to treat aortic stenosis. Wayne discusses the IPO and DurAVR’s development, the future of Anteris Technologies, and why the company has chosen Minnesota as the site of its global headquarters.

Send us a message!

Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.

  continue reading

262 episodes

Artwork
iconShare
 
Manage episode 465884542 series 2892873
Content provided by Medical Alley. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medical Alley or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

On this episode of The Medical Alley Podcast, we have a conversation with Wayne Paterson, CEO and Managing Director of Anteris Technologies.

In late December of 2024, Anteris Technologies launched an IPO to support the development of DurAVR, a Transcatheter Heart Valve (THV) designed to treat aortic stenosis. Wayne discusses the IPO and DurAVR’s development, the future of Anteris Technologies, and why the company has chosen Minnesota as the site of its global headquarters.

Send us a message!

Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.

  continue reading

262 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play